Hi Guest Login
Home > Tests > CMV Qualitative, PCR > Lucknow
₹6860 ₹5488
Report Time
Report by Tue/Thur/Fri/Mon after 7 pmFREE
Home Sample Collection
Age Group
Parameters Included
1
Recomended for
Both
Fasting
No Fasting Required
Report Time
Report by Tue/Thur/Fri/Mon after 7 pm
Exclusive Offer
₹5488
₹6860
FREE Home Sample Collection*
FREE Smart Report
Get a callback from our Health advisor.
Understanding the Test
Test Measures
City Price Info
The CMV Qualitative PCR Test is a highly sensitive molecular diagnostic test used to detect the presence of Cytomegalovirus (CMV) DNA in blood or other body fluids. For patients in Lucknow region, this test is readily available, often through convenient home sample collection services. CMV is a common virus that typically remains dormant in healthy individuals but can cause serious infections in immunocompromised patients, including transplant recipients, individuals living with HIV, and those receiving immunosuppressive therapy. By identifying active CMV infection or viral reactivation at an early stage, this test supports timely diagnosis, treatment planning, and ongoing monitoring, helping reduce the risk of complications affecting organs such as the lungs, liver, gastrointestinal tract, eyes, and central nervous system.
The CMV Qualitative PCR Test measures the presence or absence of Cytomegalovirus (CMV) genetic material (DNA) in a patient’s sample. Unlike quantitative PCR tests that determine the amount of virus present, this test focuses on confirming whether CMV DNA can be detected, helping clinicians establish if an active infection or viral reactivation is likely. The test evaluates CMV DNA detection status, which serves as an important indicator of current viral activity. A positive result suggests the presence of CMV DNA and may indicate active infection or recent viral reactivation, while a negative result indicates that CMV DNA was not detected in the sample. These findings help healthcare providers in Lucknow make informed decisions regarding further investigations, antiviral therapy, and ongoing patient monitoring, which is critical in a region with a high volume of transplant and immunocompromised patients. Schedule this test near you in Lucknow with at-home sample collection. Book an appointment today.
The CMV Qualitative PCR test is a molecular diagnostic tool that detects the presence or absence of Cytomegalovirus (CMV) DNA in blood or other body fluids, such as urine or cerebrospinal fluid.
Unlike quantitative tests that measure viral load, qualitative PCR tests determine whether the virus is present or absent.
CMV is a common herpesvirus that remains dormant in healthy individuals but can reactivate or cause primary infection in those with weakened immune systems, especially transplant recipients, HIV patients, and individuals on immunosuppressive therapy.
️Post-transplant patients should undergo routine CMV testing even without symptoms, as reactivation can occur silently.
A persistent or unexplained fever lasting several days or weeks may indicate disseminated CMV infection, where the virus spreads throughout the body. This is particularly concerning in immunocompromised individuals and often requires prompt testing to identify the cause.
Ongoing fatigue, weakness, and muscle aches may resemble a flu-like illness and are common in CMV mononucleosis-like syndrome. These symptoms often persist longer than those of typical viral infections, raising suspicion of CMV.
Difficulty breathing and a dry cough may indicate CMV pneumonitis, a serious lung infection. This condition is more common in transplant recipients or immunosuppressed patients and requires early detection to prevent complications.
Frequent loose stools, abdominal discomfort, or cramping may indicate CMV colitis, a condition characterized by inflammation of the colon. This is often seen in individuals with weakened immune systems and requires timely diagnosis and treatment.
Visual disturbances such as blurred vision, floaters, or vision loss may indicate CMV retinitis, particularly in people living with HIV. This serious condition can lead to permanent blindness if not diagnosed and treated early.
Yellowing of the skin or eyes (jaundice) and abnormal liver function tests may suggest CMV hepatitis, which results from viral infection of the liver and leads to inflammation and impaired function.
Neurological symptoms such as seizures, confusion, or altered mental status may indicate CMV encephalitis, a rare but severe brain infection. Immediate medical evaluation and testing are essential to prevent life-threatening outcomes.
The CMV Qualitative PCR test is essential for early screening, diagnosis, and detection of CMV infection.
The test supports the diagnosis of active CMV infection when symptoms such as fever, fatigue, or organ-specific issues, such as pneumonia, hepatitis, or colitis, are present.
Before organ or stem cell transplantation, both donor and recipient may be tested to assess the risk of CMV transmission or reactivation after transplant.
In immunocompromised individuals, routine qualitative testing helps detect viral reactivation before symptoms appear, enabling preemptive treatment.
A positive result indicates the need for antiviral medications such as ganciclovir or valganciclovir, while a negative result may rule out active CMV disease.
Serial qualitative tests, showing conversion from positive to negative, suggest a positive response to antiviral therapy, but a negative result does not guarantee complete viral clearance.
The CMV Qualitative PCR test detects Cytomegalovirus (CMV) DNA in blood or other body fluids. Unlike quantitative tests, it confirms whether the virus is present or absent. This is especially useful for early diagnosis, screening immunocompromised patients, and guiding timely clinical decisions before symptoms become severe.
|
Parameter |
Description |
|
CMV DNA Detection |
Determines whether CMV genetic material is present in the sample. |
|
Infection Status |
Positive = CMV DNA detected, consistent with active infection or recent reactivation. Negative = no detectable virus. |
|
Clinical Decision Point |
Helps initiate, adjust, or stop antiviral therapy based on the presence/absence of the virus. |
This test is primarily recommended for individuals at high risk of CMV-related complications due to immune suppression.
Patients who have undergone kidney, liver, heart, lung, or pancreas transplants are at higher risk of CMV infection due to lifelong immunosuppression. CMV is a common opportunistic infection in this group and can directly affect the transplanted organ, leading to graft dysfunction or failure if not detected early. Regular CMV testing enables timely intervention and supports long-term transplant outcomes.
Individuals who have received stem cell or bone marrow transplants are highly vulnerable to CMV reactivation, especially within the first 100 days after the procedure. During this period, the immune system is severely weakened, increasing the risk of serious complications such as CMV pneumonia or gastrointestinal disease. Early screening and monitoring are crucial to prevent life-threatening outcomes.
People living with HIV, especially those with a CD4 count below 100 cells/µL, are at high risk for severe CMV-related complications. These may include CMV retinitis, encephalitis, and colitis. Early detection is essential to initiate prompt antiviral therapy and prevent irreversible damage.
Patients receiving treatments that suppress the immune system, such as chemotherapy, biologic agents like rituximab, or high-dose corticosteroids, are more susceptible to CMV infection or reactivation. Reduced immune defenses can allow latent CMV infection to become active and symptomatic. Monitoring with CMV testing helps manage risks and adjust treatment plans as needed.
Newborns suspected of congenital CMV infection may present with symptoms such as microcephaly, hearing loss, jaundice, or petechiae. Early diagnosis is critical, as congenital CMV can cause long-term developmental and neurological complications. Timely testing enables early intervention and supportive care.
Even individuals with a normal immune system may occasionally develop CMV-related illness. Symptoms such as unexplained fever, hepatitis, mononucleosis-like syndrome, or pneumonia may raise suspicion of CMV infection. In these cases, CMV testing helps confirm the diagnosis and ensures appropriate management, especially when symptoms persist or other causes have been excluded.
Understanding the basic specifications of the CMV Qualitative PCR test helps patients and caregivers prepare and know what to expect. The test is simple, requires no special preparation, and can be performed using various clinical samples depending on the patient’s condition. Below is a summary of key test details:
|
Parameter |
Details |
|
Test Name |
CMV Qualitative PCR |
|
Also Known As |
Cytomegalovirus DNA PCR (Qualitative) |
|
Sample Type |
Blood (EDTA tube), Urine, CSF, or BAL fluid |
|
Gender |
Both |
|
Age Group |
All |
|
Fasting Required |
No |
|
Report Time |
24–48 Hours |
|
Home Collection |
Available (with MAX@Home) |
Several clinical and technical factors can affect the accuracy and interpretation of a CMV qualitative PCR test. Understanding these variables helps clinicians avoid misdiagnosis, especially in high-risk patients, and ensures results are interpreted in the correct clinical context.
The timing of the test is crucial for accuracy. If performed too early after infection or exposure, viral DNA levels may be too low to detect, resulting in a false-negative result. Re-testing may be necessary if clinical suspicion remains high.
The degree of immunosuppression significantly affects test outcomes. Patients with severe immunosuppression, such as transplant recipients or those on intensive therapies, have a higher risk of CMV reactivation and are more likely to test positive.
Patients receiving antiviral medications as a preventive measure may have suppressed viral replication. This can reduce CMV DNA levels below the detection threshold, potentially resulting in a false-negative despite underlying infection.
The type of sample collected can impact detection. Blood samples are typically used to detect viremia. In contrast, other samples, such as urine or bronchoalveolar lavage (BAL) fluid,d may show CMV presence even when blood tests are negative, especially in localized infections.
Proper handling and timely processing of the sample are essential for accurate results. Delays or improper storage can degrade viral DNA, leading to false-negative results and reduced test reliability.
The CMV Qualitative PCR test indicates whether Cytomegalovirus (CMV) DNA is present in the sample. Correct interpretation requires understanding the clinical context, patient risk factors, and symptoms. Below is a simple explanation of possible results:
|
Result |
Interpretation |
Next Steps |
|
Not Detected |
No active CMV infection (or viral load below test detection limit). |
Monitor clinically; repeat testing if symptoms persist. |
|
Detected |
CMV DNA detected; suggests active CMV infection (primary, reactivation, or reinfection). Requires clinical correlation. |
Consider antiviral therapy; perform quantitative PCR for viral load; assess end-organ disease. |
Important: A “Detected” result should always be interpreted in a clinical context, including symptoms, immune status, and organ function. In transplant patients, even low-level detection may require preemptive therapy.
Choosing the right diagnostic provider is essential for accurate results, timely diagnosis, and a smooth healthcare experience. MAX@Home combines advanced diagnostic technology with patient-focused services, ensuring reliable CMV testing at home while maintaining high clinical standards.
Sample collection is performed by highly trained and certified phlebotomists who follow strict infection control and hygiene protocols. They ensure a safe, professional experience, which is especially important for elderly patients, children, and immunocompromised individuals.
All samples are processed in NABL-accredited laboratories that follow stringent quality control measures. This ensures high accuracy, consistency, and reliability of results, minimizing diagnostic errors.
MAX@Home uses advanced real-time PCR technology, known for high sensitivity and specificity. This enables detection of low levels of CMV DNA, supporting early diagnosis and improved clinical decision-making.
You can schedule your CMV test at a convenient time, with doorstep sample collection eliminating the need to visit hospitals or diagnostic centers. This reduces exposure risk and saves time, making it ideal for busy professionals and high-risk patients.
From booking your test online or by phone to timely sample collection and quick digital report delivery, MAX@Home provides complete support throughout the process. The team also assists with queries and follow-ups to ensure a smooth experience.
Reports are typically delivered within 24–48 hours, enabling doctors to initiate timely treatment or further investigations, which is critical in managing CMV infections.
Backed by Max Healthcare’s clinical expertise, MAX@Home brings hospital-grade diagnostics to your doorstep. Patients benefit from established protocols, experienced professionals, and a strong reputation for quality healthcare services.
The service is especially beneficial for transplant recipients, cancer patients, HIV patients, and newborns who require frequent monitoring but should avoid hospital exposure. Home testing ensures safety without compromising quality.
If you are seeking a reliable CMV Qualitative PCR test in Lucknow, MAX@Home offers accuracy, convenience, and expert care from the comfort of your home.
Early detection of CMV can prevent life-threatening complications in transplant recipients and immunocompromised patients. Do not wait for symptoms to worsen.
Read More
You've selected items to compare.
View All
MAX@Home is one of Lucknow’s leading providers of diagnostic services, with lab-test centres located across all major localities in the city.